Is Eli Lilly and Company (LLY) a Buy, Sell, or Hold?
NYSE : LLY
Eli Lilly and Company — Analyst Ratings
$1121.17 USD
-$27.67 (-2.41%)
- Volume
- 2.49M
- Average Volume
- 3.03M
- Market Capitalization
- $1.06T
- P/E Ratio
- 39.76
- Dividend Yield
- 0.58%
- Price Target
- $1300.00
- Year High
- $1249.45
- Year Low
- $623.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.22
- Current Ratio
- $1.50
Analyst Consensus Summary
Consensus Rating
Neutral
45 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-13.8%
vs Current Price
Price Target
$1300.00
Average TargetPrice Target Range
Lowest Target
$1135.00
-1.2% DOWNSIDE
Average Target
$1300.00
Median Estimate
Highest Target
$1500.00
-25.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 45
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 33 | 9 | 3 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Terence Flynn | $1347 | $1235.56 | 2026-07-08 07:37 AM | 9.0% |
| Leerink Partners | David Risinger | $1232 | $1117.26 | 2026-06-25 06:02 AM | 10.3% |
| Berenberg Bank | Kerry Holford | $1135 | $1111.67 | 2026-06-22 11:48 AM | 2.1% |